Abbott (NYSE: ABT) and WeightWatchers today announced the availability of a connected app for people living with diabetes.
In August 2022, the companies announced a collaboration to integrate continuous glucose monitoring (CGM) with the WW diabetes-tailored plan. The integrated offering provides a mobile experience with information and insights needed for those with diabetes. It helps to make healthy adjustments to their diet, improve their glucose levels and gain more control of their health.
The app helps people with diabetes understand how food and activity impact their glucose levels. WeightWatchers members who follow the tailored plan can now access their glucose data from the Abbott FreeStyle Libre 2 CGM. This all works within their WW app while under guidance from the WW diabetes-tailored plan.
Get the full story at our sister site, Drug Delivery Business News.
